Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

FDA approves Pleximmune to predict transplant rejection in children

Sep. 15, 2014

Development of a rapid MRR test for the detection of malaria

Sep. 10, 2014

Vizamyl approved in E.U. for PET imaging of beta-amyloid plaques

Sep. 1, 2014

Telik updates progress of development of 5B1 for gastrointestinal cancers

Sep. 1, 2014

Acusphere withdraws European MAA for Imagify

Sep. 1, 2014

Telik receives NCI contract to develop antibody-based PET imaging agent

Aug. 26, 2014

Paradigm to conduct genomic analysis to predict response to Tesaro's TSR-011

Aug. 25, 2014

Marketing approval granted for KRONUS ZnT8Ab ELISA Assay for diagnosis of type 1 diabetes

Aug. 21, 2014

Photocure provides update on partnership for Lumacan

Aug. 19, 2014

Neuraceq launched in U.S.

Aug. 18, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...